Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03178825 · ClinicalTrials.gov registry record · NA
Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause
A NA study of Sexual Dysfunction and Dyspareunia, sponsored by Sciton.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 6
- Study locations
NCT03178825 is a NA study of Sexual Dysfunction and Dyspareunia that has completed, run by Sciton. The registered enrollment target is 60 participants, below the 965-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (94% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT03178825, a NA study of Sexual Dysfunction and Dyspareunia, has completed, sponsored by Sciton.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 6
- Study locations
Study Summary
This multi-center clinical trial will evaluate the safety and long-term efficacy of hybrid fractional 2940 nm and 1470 nm lasers for treatment of symptoms of Genitourinary Syndrome of Menopause.
Conditions Studied
Interventions
- DEVICE Hybrid Fractional Laser
Study Locations (6)
California
- Women's Pelvic Health Institute - Los Gatos
Florida
- Coyle Institute - Pensacola
Louisiana
- Louisiana State University - New Orleans
North Carolina
- Carolinas Healthcare System - Charlotte
Texas
- Woodlands Gynecology & Aesthetics - The Woodlands
Virginia
- The Female Pelvic Medicine Institute of Virginia - North Chesterfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-05-19 |
| Est. Completion | 2020-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03178825
The ClinicalTrials.gov registry entry for NCT03178825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 965-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (94% lower). The listed sponsor is Sciton, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Sexual Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Hybrid Fractional Laser is the first listed.
NCT03178825 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Louisiana.
Frequently Asked Questions
What is clinical trial NCT03178825 about?
NCT03178825 is a clinical study titled "Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause". This multi-center clinical trial will evaluate the safety and long-term efficacy of hybrid fractional 2940 nm and 1470 nm lasers for treatment of symptoms of Genitourinary Syndrome of Menopause.
What is the current status of trial NCT03178825?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-05-19. Estimated completion is 2020-02-25.
What conditions does trial NCT03178825 study?
This clinical trial studies the following conditions: Sexual Dysfunction, Dyspareunia, Vaginal Atrophy, Vaginal Dryness, Chronic UTI.
What interventions are being tested in trial NCT03178825?
The interventions under investigation include: Hybrid Fractional Laser (DEVICE).
Who is sponsoring clinical trial NCT03178825?
This trial is sponsored by Sciton, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03178825 being conducted?
This trial has 6 study locations across California, Florida, Louisiana, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexual Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
RECRUITING · NA
-
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
RECRUITING · NA
-
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
RECRUITING · NA
-
Prostate Stimulation for Sexual Dysfunction
RECRUITING · NA
-
AYA OMGYES Sexual Health Study
RECRUITING · NA
-
Improving Women's Function After Pelvic Radiation
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.